AstraZeneca Q4 Core Earnings Beat Estimates Despite Esing COVID Vaccine Demand
Feb 9, 2023
AstraZeneca PLC (LON:AZN) posted better-than-expected core income in the fourth quarter, thanks to strong demand for its cancer and rare disease therapies that helped make up for waning sales of its COVID-19 vaccine. Core earnings per share during the three months ended on
UBS has No Desire to Buy Credit Suisse, Chairman Tells Newspaper
Jan 14, 2023
UBS has no interest in buying fellow Swiss lender Credit Suisse, the bank’s Chairman Colm Kelleher said in a interview published on Saturday. The former Morgan Stanley (NYSE:MS) president said he was focused on organic growth rather than acquisitions and expanding its business
Recent Comments